Nasmed Ozel Saglik Hizmetleri Ticaret AS (EGEPO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nasmed Ozel Saglik Hizmetleri Ticaret AS (EGEPO) has a cash flow conversion efficiency ratio of 0.093x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL129.90 Million ≈ $2.91 Million USD) by net assets (TL1.39 Billion ≈ $31.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see EGEPO market cap for the company's overall valuation and market capitalisation.
Nasmed Ozel Saglik Hizmetleri Ticaret AS - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Nasmed Ozel Saglik Hizmetleri Ticaret AS's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nasmed Ozel Saglik Hizmetleri Ticaret AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nasmed Ozel Saglik Hizmetleri Ticaret AS ranked by their cash flow conversion efficiency. Explore Nasmed Ozel Saglik Hizmetleri Ticaret AS earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Senkron Guvenlik ve Iletisim Sistemleri AS
IS:SNKRN
|
0.017x |
|
AurosTechnology Inc.
KQ:322310
|
0.037x |
|
KKB Engineering Berhad
KLSE:9466
|
-0.035x |
|
Pieridae Energy Ltd
TO:PEA
|
0.170x |
|
Island Pharmaceuticals Ltd
AU:ILA
|
-0.237x |
|
Smart Gunes Enerjisi Teknolojileri Arastirma Gelistirme Uretim Sanayi ve Ticaret
IS:SMRTG
|
0.134x |
|
SNC Former Public Company Limited
BK:SNC
|
0.072x |
|
West Vault Mining
V:WVM
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Nasmed Ozel Saglik Hizmetleri Ticaret AS (2019–2024)
The table below shows the annual cash flow conversion efficiency of Nasmed Ozel Saglik Hizmetleri Ticaret AS from 2019 to 2024. View Nasmed Ozel Saglik Hizmetleri Ticaret AS share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | TL1.39 Billion ≈ $31.20 Million |
TL200.54 Million ≈ $4.49 Million |
0.144x | +61.80% |
| 2023-12-31 | TL1.42 Billion ≈ $31.76 Million |
TL126.17 Million ≈ $2.83 Million |
0.089x | +159.45% |
| 2022-12-31 | TL295.83 Million ≈ $6.63 Million |
TL10.14 Million ≈ $227.22K |
0.034x | -63.29% |
| 2021-12-31 | TL293.31 Million ≈ $6.57 Million |
TL27.40 Million ≈ $613.60K |
0.093x | -63.64% |
| 2020-12-31 | TL125.52 Million ≈ $2.81 Million |
TL32.25 Million ≈ $722.22K |
0.257x | +35.24% |
| 2019-12-31 | TL92.95 Million ≈ $2.08 Million |
TL17.66 Million ≈ $395.46K |
0.190x | -- |
About Nasmed Ozel Saglik Hizmetleri Ticaret AS
Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi provides healthcare services in Turkey. The company's medical units include oral and dental health; anesthesiology and reanimation; nutrition and diet; brain and nerve surgery; childhood diseases; dermatology; endocrinology and metabolic diseases; infectious diseases and clinical microbiology; aesthetic, plastic, and reconstructive surgery; hom… Read more